Corvus Pharmaceuticals Inc (CRVS)

Income Before Tax

-$53.42M

TTM · Period ending: · USD

CRVS logo

CRVS Income Before Tax

Latest reported-$53.42M
CRVS TTM Pre-Tax Income (-$31.34M → -$53.42M)
High-resolution chart · PNG

CRVS income before tax history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Corvus Pharmaceuticals Inc Income Before Tax — Trailing twelve months (TTM) (USD)
Period endingIncome Before Tax (USD)
-53,420,000
-44,168,000
-15,283,000
-15,075,000
-45,135,000
-41,399,000
-62,293,000
-56,833,000
-22,616,000
-24,857,000
-27,029,000
-30,192,000
-39,023,000
-40,883,000
-41,307,000
-40,727,000
-36,569,000
-39,958,000
-43,241,000
-6,658,000
-5,781,000
-4,640,000
-5,995,000
-44,389,000
-45,597,000
-47,964,000
-46,672,000
-46,134,000
-45,628,000
-44,281,000
-46,939,000
-48,359,000
-50,578,000
-53,928,000
-55,663,000
-54,820,000
-52,400,000
-46,064,000
-36,375,000
-31,328,000
-24,182,000
-35,769,000
-31,335,000
-25,450,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.